By Devika Patel
Knoxville, Tenn., Oct. 19 - Theralase Technologies Inc. said it has extended the deadline for completing a C$1.2 million private placement of units to Nov. 19. The deal priced Sept. 30 and originally was to settle Oct. 15.
The company is selling units of one common share and one half-share warrant at C$0.30 apiece. Each whole two-year warrant is exercisable at C$0.45.
Proceeds will be used for sales and marketing and TLC-2000 biomedical laser commercialization.
Theralase is a Toronto-based manufacturer of high-powered, super-pulsed therapeutic laser equipment.
| Issuer: | Theralase Technologies Inc.
|
| Issue: | Units of one common share and one half-share warrant
|
| Amount: | C$1.2 million
|
| Price: | C$0.30
|
| Warrants: | One half-share warrant per unit
|
| Warrant expiration: | Two years
|
| Warrant strike price: | C$0.45
|
| Pricing date: | Sept. 30
|
| Amended: | Oct. 19
|
| Settlement date: | Nov. 19
|
| Stock symbol: | TSX Venture: TLT
|
| Stock price: | C$0.42 at close Sept. 30
|
| Market capitalization: | C$10.5 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
